AGF Investments Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$1.39M Buy
35,946
+1,494
+4% +$59.9K 0.01% 312
2022
Q2
$1.28M Buy
34,452
+946
+3% +$38.5K 0.01% 323
2022
Q1
$1.48M Hold
33,506
0.01% 340
2021
Q4
$1.42M Buy
33,506
+1,088
+3% +$45.7K 0.01% 383
2021
Q3
$1.41M Buy
32,418
+616
+2% +$27.3K 0.01% 375
2021
Q2
$1.36M Buy
31,802
+532
+2% +$22.4K 0.01% 383
2021
Q1
$1.21M Buy
31,270
+38
+0.1% +$1.44K 0.01% 390
2020
Q4
$1.12M Sell
31,232
-15,233
-33% -$549K 0.01% 374
2020
Q3
$1.77M Buy
46,465
+16,632
+56% +$641K 0.02% 295
2020
Q2
$1.05M Sell
29,833
-2,735
-8% -$98.5K 0.01% 352
2020
Q1
$1.06M Buy
32,568
+1,129
+4% +$44.1K 0.01% 312
2019
Q4
$1.42M Buy
31,439
+2,081
+7% +$87.1K 0.02% 268
2019
Q3
$1.2M Buy
29,358
+6,371
+28% +$270K 0.02% 267
2019
Q2
$988K Buy
22,987
+1,345
+6% +$51.7K 0.01% 281
2019
Q1
$831K Buy
21,642
+1,307
+6% +$49.9K 0.01% 298
2018
Q4
$719K Buy
+20,335
New +$738K 0.01% 315

Other funds holding BSX

AGF Investments Inc's BSX Position: Q3 2022 in Review

AGF Investments Inc increased its Boston Scientific (BSX) stake by 4.3% in Q3 2022, buying an estimated $59.9K and bringing the position to 35,946 shares worth $1.39M. The position accounts for 0.01% of the portfolio, ranked #312.

AGF Investments Inc first reported a position in BSX in Q4 2018 and has held it in 16 quarters since. The position peaked at $1.77M in Q3 2020. 866 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • AGF Investments Inc held 35,946 shares of Boston Scientific worth $1.39M as of Q3 2022.
  • AGF Investments Inc bought 1,494 Boston Scientific shares in Q3 2022, an estimated $59.9K.
  • Boston Scientific made up 0.01% of AGF Investments Inc's portfolio in Q3 2022, its #312 holding.
  • AGF Investments Inc first reported a position in Boston Scientific in Q4 2018 and has held it in 16 quarters since.
  • AGF Investments Inc's Boston Scientific position peaked at $1.77M in Q3 2020.
  • 866 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on AGF Investments Inc's 13F filing for Q3 2022, filed 10 Nov 2022.